Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Total 13F shares
-
19,072,268
-
Share change
-
+3,681,140
-
Total reported value
-
$372,436,000
-
Price per share
-
$19.53
-
Number of holders
-
16
-
Value change
-
+$73,098,989
-
Number of buys
-
8
-
Number of sells
-
17
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q2 2021
As of 30 Jun 2021,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,072,268 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock Inc., BOXER CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LP, RTW INVESTMENTS, LP, JANUS HENDERSON GROUP PLC, Octagon Capital Advisors LP, and Old Well Partners, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.